SUBSCRIBE
SUBSCRIBE

Dimension Therapeutics

NEWS
Dimension Therapeutics was acquired by Ultragenyx in 2017.
Proteostasis and Roche Diagnostics Ink Huge Space in New Boston Hub
Deals
Bay Area’s Ultragenyx Swoops in With $138 Million Bid for Almost-Sold Dimension Therapeutics
September 18, 2017
 · 
3 min read
Bay Area Startup Arcus Biosciences Lands $307 Million+ Deal With Taiho Pharma
Deals
Troubled Dimension Therapeutics Sold in All-Stock Deal
August 25, 2017
 · 
2 min read
Massachusetts' Biostage Slashes 71% of Staff, Evaluating Strategic Alternatives
Business
Dimension Therapeutics Pink Slips 25% of Workforce
June 27, 2017
 · 
2 min read
Wall Street's Top Biotech Analyst Loves These 2 Life Science Stocks
Drug Development
Cambridge’s Dimension Therapeutics Tanks to a New Low After Revealing Interim Hemophilia B Data
February 1, 2017
 · 
2 min read
Here’s Why 5 Billionaire-Led Funds Gobbled Up 3.3 Million Shares of Celldex Stock
BioCapital
3 Biotech Stocks Flying High Under-the-Radar
May 26, 2016
 · 
3 min read
Biogen Idec Alzheimer's Drug Aducanumab Exceeds Expectations
Job Trends
Like Dimension Therapeutics, More Than Half of Yumanity’s Employees are Women
February 11, 2016
 · 
2 min read
Here’s Why 5 Billionaire-Led Funds Gobbled Up 3.3 Million Shares of Celldex Stock
Genetown
Cambridge’s Dimension Therapeutics Nabs $65 Million
April 21, 2015
 · 
2 min read
AWARDS
  • NextGen Class of 2015
IN THE PRESS
Business
Dimension Therapeutics Announces Management Change
July 24, 2017
 · 
2 min read
Drug Development
Dimension Therapeutics Throws In The Towel On Hemophilia B Drug
May 10, 2017
 · 
7 min read
Business
Aptuit LLC And Dimension Therapeutics Enter Strategic Partnership To Advance Select Dimension Programs Toward IND Filing
July 7, 2016
 · 
4 min read
Drug Development
Dimension Therapeutics Announces Preclinical Data From Bayer-Partnered Hemophilia A Program At American Society For Gene And Cell Therapy (ASGCT) Annual Meeting
May 9, 2016
 · 
4 min read
Business
Dimension Therapeutics Reports Recent Corporate Progress and Third Quarter 2015 Financial Results
December 7, 2015
 · 
7 min read
Job Trends
Dimension Therapeutics Inks Huge Lease for a New Lab and Office Space in Woburn
November 4, 2015
 · 
5 min read
Deals
Dimension Therapeutics Prices IPO at Lower End of the Range But Still Manages to Reel in $72 Million
October 22, 2015
 · 
2 min read
Business
Dimension Therapeutics Elects Dr. Alan B. Colowick To Its Board Of Directors
September 22, 2015
 · 
3 min read
Drug Development
Dimension Therapeutics Announces FDA Fast Track Designation For Lead Candidate DTX101 In Patients With Hemophilia B
September 17, 2015
 · 
3 min read
Deals
Cambridge’s Dimension Therapeutics Preps for $115 Million IPO
September 14, 2015
 · 
1 min read
Load More